Tybost (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Tybost drug offered from Gilead Sciences, Inc.. This Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
NON-PROPRIETARY NAME: | COBICISTAT |
SUBSTANCE NAME: | COBICISTAT |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-09-24 |
END MARKETING DATE: | 0000-00-00 |
Tybost HUMAN PRESCRIPTION DRUG Details:
Item Description | Tybost from Gilead Sciences, Inc. |
LABELER NAME: | Gilead Sciences, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2014-09-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61958-1401_a7e53701-1c4c-428e-8df6-61e816c730d5 |
PRODUCT NDC: | 61958-1401 |
APPLICATION NUMBER: | NDA203094 |
Other COBICISTAT Pharmaceutical Manufacturers / Labelers: